Interrelationships Between Sclerostin, Secondary Hyperparathyroidism, and Bone Metabolism in Patients on Hemodialysis.
Nakagawa Y, Komaba H, Hamano N, Tanaka H, Wada T, Ishida H, Nakamura M, Takahashi H, Takahashi Y, Hyodo T, Hida M, Suga T, Kakuta T, Fukagawa M.
Nakagawa Y, et al.
J Clin Endocrinol Metab. 2022 Jan 1;107(1):e95-e105. doi: 10.1210/clinem/dgab623.
J Clin Endocrinol Metab. 2022.
PMID: 34423837